Table 5

The 30-d postoperative outcomes between patients with 3 to 4 stents and controls.

30-d Medical Complications3–4 Stents
(n = 1578)
Control
(n = 707,396)
P Value3-4 Stents vs Control,
Adjusted OR (95% CI)
P Value
Major
 Pulmonary embolus5 (0.3%)1968 (0.3%)0.9590.71 (0.25–1.53)0.439
 Pneumonia16 (1.0%)3775 (0.5%)0.0150.90 (0.52–1.43)0.680
 CVA3 (0.2%)874 (0.1%)0.6940.66 (0.16–1.72)0.472
MI 9 (0.6%) 776 (0.1%) <0.001 2.26 (1.08–4.14) 0.016
 Sepsis17 (1.1%)2760 (0.4%)<0.0011.33 (0.79–2.09)0.242
 Death2 (0.1%)601 (0.1%)0.8910.62 (0.10–1.93)0.497
Minor
 AKI15 (1.0%)4192 (0.6%)0.0920.67 (0.38–1.07)0.123
 UTI42 (2.7%)11,275 (1.6%)0.0011.00 (0.72–1.34)0.979
 Wound complications36 (2.3%)11,031 (1.6%)0.0270.99 (0.70–1.37)0.975
 Transfusion23 (1.5%)3776 (0.5%)<0.0011.46 (0.94–2.16)0.075
 DVT7 (0.4%)2962 (0.4%)10.67 (0.29–1.31)0.300
30-d Readmission108 (6.8%)29,761 (4.2%)<0.0011.00 (0.82–1.22)0.985
  • Abbreviations: AKI, acute kidney injury; CVA, cerebrovascular accident; DVT, deep vein thrombosis; MI, myocardial infarction; UTI, urinary tract infection.

  • Note: Values in bold denote statistical significance determined by P < 0.05.